Insider filing · CRNX
Jeff E. Knight
Chief Operating Officer
profile →
Crinetics Pharmaceuticals, Inc.
CRNX · Healthcare · 30 filings in 24 months
ticker →
Jeff E. Knight sold $3.4M of Crinetics Pharmaceuticals (CRNX)
Executed Apr 8, disclosed Apr 10, 2 days later.
Value, as filed
$3.4M
85,163 sh × $40.10
Executed
Apr 8
the trade date, as filed
Disclosed
Apr 10
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JKJeff E. Knight (Chief Operating Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $3.4M of CRNX (85,163 sh × $40.10, as filed), executed Apr 8.
The name
CRNXHealthcare · Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of n…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeff E. Knight in CRNX
CRNXSALE
Crinetics Pharmaceuticals, Inc.
$370K9,911 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. $232K
6,801 sh × $34.17
Exec Mar 19 2025
Filed Mar 21 2025 · 5:30 PM ET